TXK
Basic information
Region (hg38): 4:48063158-48134250
Previous symbols: [ "PTK4" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TXK gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 33 | 33 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 33 | 0 | 0 |
Variants in TXK
This is a list of pathogenic ClinVar variants found in the TXK region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-48067666-C-T | not specified | Uncertain significance (Jan 31, 2022) | ||
4-48067669-G-A | not specified | Uncertain significance (Jun 06, 2022) | ||
4-48067678-C-T | not specified | Uncertain significance (Jul 14, 2022) | ||
4-48071520-A-C | not specified | Uncertain significance (Jun 24, 2022) | ||
4-48071561-C-T | not specified | Uncertain significance (Jun 17, 2024) | ||
4-48071597-T-C | not specified | Uncertain significance (Dec 13, 2023) | ||
4-48071606-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
4-48071618-T-C | not specified | Uncertain significance (Feb 27, 2024) | ||
4-48071618-T-G | not specified | Uncertain significance (Jun 26, 2023) | ||
4-48071671-A-T | not specified | Uncertain significance (Mar 07, 2024) | ||
4-48074028-T-C | not specified | Uncertain significance (Aug 12, 2021) | ||
4-48076445-T-C | not specified | Uncertain significance (Dec 27, 2023) | ||
4-48076453-C-T | not specified | Uncertain significance (Jan 16, 2024) | ||
4-48076460-T-C | not specified | Uncertain significance (Aug 12, 2021) | ||
4-48079982-A-T | not specified | Uncertain significance (Jun 22, 2023) | ||
4-48080024-T-G | not specified | Uncertain significance (Dec 01, 2022) | ||
4-48080126-T-C | not specified | Uncertain significance (Dec 03, 2021) | ||
4-48080127-T-G | not specified | Uncertain significance (Mar 16, 2022) | ||
4-48086517-T-C | not specified | Uncertain significance (Dec 06, 2022) | ||
4-48086545-G-A | not specified | Uncertain significance (Jul 16, 2021) | ||
4-48086586-C-T | not specified | Uncertain significance (May 30, 2023) | ||
4-48086629-C-T | not specified | Uncertain significance (Jul 15, 2021) | ||
4-48094103-A-T | not specified | Uncertain significance (Jul 20, 2022) | ||
4-48094116-T-C | not specified | Uncertain significance (Feb 05, 2024) | ||
4-48094121-T-C | not specified | Uncertain significance (Oct 27, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TXK | protein_coding | protein_coding | ENST00000264316 | 15 | 67864 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.57e-9 | 0.995 | 125683 | 0 | 65 | 125748 | 0.000258 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.917 | 247 | 291 | 0.849 | 0.0000152 | 3452 |
Missense in Polyphen | 72 | 110.95 | 0.64894 | 1390 | ||
Synonymous | -0.519 | 105 | 98.4 | 1.07 | 0.00000507 | 935 |
Loss of Function | 2.59 | 19 | 35.7 | 0.533 | 0.00000178 | 431 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000689 | 0.000688 |
Ashkenazi Jewish | 0.0000994 | 0.0000992 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.000324 | 0.000323 |
European (Non-Finnish) | 0.000194 | 0.000193 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000267 | 0.000261 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Non-receptor tyrosine kinase that plays a redundant role with ITK in regulation of the adaptive immune response. Regulates the development, function and differentiation of conventional T- cells and nonconventional NKT-cells. When antigen presenting cells (APC) activate T-cell receptor (TCR), a series of phosphorylation lead to the recruitment of TXK to the cell membrane, where it is phosphorylated at Tyr-420. Phosphorylation leads to TXK full activation. Contributes also to signaling from many receptors and participates in multiple downstream pathways, including regulation of the actin cytoskeleton. Like ITK, can phosphorylate PLCG1, leading to its localization in lipid rafts and activation, followed by subsequent cleavage of its substrates. In turn, the endoplasmic reticulum releases calcium in the cytoplasm and the nuclear activator of activated T-cells (NFAT) translocates into the nucleus to perform its transcriptional duty. With PARP1 and EEF1A1, TXK forms a complex that acts as a T-helper 1 (Th1) cell- specific transcription factor and binds the promoter of IFNG to directly regulate its transcription, and is thus involved importantly in Th1 cytokine production. Phosphorylates both PARP1 and EEF1A1. Phosphorylates also key sites in LCP2 leading to the up-regulation of Th1 preferred cytokine IL-2. Phosphorylates 'Tyr- 201' of CTLA4 which leads to the association of PI-3 kinase with the CTLA4 receptor. {ECO:0000269|PubMed:10523612, ECO:0000269|PubMed:11564877, ECO:0000269|PubMed:11859127, ECO:0000269|PubMed:17177976, ECO:0000269|PubMed:9813138}.;
- Pathway
- Leukocyte transendothelial migration - Homo sapiens (human);Focal Adhesion;FCERI mediated Ca+2 mobilization;Fc epsilon receptor (FCERI) signaling;TCR;Innate Immune System;Immune System
(Consensus)
Recessive Scores
- pRec
- 0.0980
Intolerance Scores
- loftool
- 0.489
- rvis_EVS
- -0.16
- rvis_percentile_EVS
- 42.06
Haploinsufficiency Scores
- pHI
- 0.0682
- hipred
- N
- hipred_score
- 0.196
- ghis
- 0.498
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.584
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Txk
- Phenotype
- immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- cytokine production;adaptive immune response;regulation of transcription by RNA polymerase II;protein phosphorylation;activation of phospholipase C activity;positive regulation of interferon-gamma production;peptidyl-tyrosine autophosphorylation;positive regulation of transcription by RNA polymerase II;protein autophosphorylation;T cell receptor signaling pathway;positive regulation of interferon-gamma-mediated signaling pathway
- Cellular component
- nucleus;cytoplasm;plasma membrane
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II regulatory region DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;non-membrane spanning protein tyrosine kinase activity;protein binding;ATP binding